High dose of histone deacetylase inhibitors affects insulin secretory mechanism of pancreatic beta cell line
Objective. Histone deacytylase inhibitors (HDACis) inhibit the deacetylation of the lysine residue of proteins, including histones, and regulate the transcription of a variety of genes. Recently, HDACis have been used clinically as anti-cancer drugs and possible anti-diabetic drugs. Even though HDAC...
Enregistré dans:
Auteur principal: | |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Sciendo
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a1331ef46d6d46e983349cdeb35e1fdb |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Soyez le premier à ajouter un commentaire!